A detailed history of Farther Finance Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 2,302 shares of VRTX stock, worth $1.19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,302
Previous 2,312 0.43%
Holding current value
$1.19 Million
Previous $1.09 Billion 1.74%
% of portfolio
0.04%
Previous 0.05%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$460.0 - $505.78 $4,600 - $5,057
-10 Reduced 0.43%
2,302 $1.07 Billion
Q2 2024

Jul 31, 2024

BUY
$392.81 - $485.53 $579,787 - $716,642
1,476 Added 176.56%
2,312 $1.09 Billion
Q1 2024

May 13, 2024

BUY
$407.69 - $446.08 $281,713 - $308,241
691 Added 476.55%
836 $352 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $176,645 - $211,500
515 Added 241.78%
728 $296 Million
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $22,996 - $24,647
68 Added 46.9%
213 $74.1 Million
Q2 2023

May 13, 2024

BUY
$314.42 - $351.91 $2,515 - $2,815
8 Added 5.84%
145 $51 Million
Q2 2023

Sep 12, 2023

BUY
$314.42 - $351.91 $2,515 - $2,815
8 Added 5.84%
145 $51 Million
Q1 2023

May 13, 2024

SELL
$283.23 - $323.1 $167,388 - $190,952
-591 Reduced 81.18%
137 $43.2 Million
Q1 2023

Sep 12, 2023

SELL
$283.23 - $323.1 $10,479 - $11,954
-37 Reduced 21.26%
137 $43.2 Million
Q4 2022

Sep 11, 2023

BUY
$285.76 - $321.48 $49,722 - $55,937
174 New
174 $50.2 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.